Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge
Forecasted Federal grant Posted
- Opportunity number
- CDC-RFA-DD-27-0028
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Applications expected due
- Award size
- Not on record
Opportunity facts
- Expected posting
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Non-501(c)(3) Nonprofits
- 501(c)(3) Nonprofits
- Higher Education Inst. (Private)
- Higher Education Inst. (Public)
- County Governments
- Independent School Districts
- Other
- For Profit Organizations
- Small Businesses
- Tribal Organizations (Not Federally Recognized)
- Unrestricted
- Special District Governments
- Public or Indian Housing Auth.
- State Governments
- City/Township Governments
- Tribal Governments (Federally Recognized)
- Points of contact
-
- Amanda Akosa kcq9@cdc.gov (404) 718-3409
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention is soliciting applications for cooperative agreements to implement Notice of Funding Opportunity DD-27-0028, Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge, with no hard deadline date provided in this forecast. Applicants may apply for only one of three components; applications naming multiple components or strategies will be deemed non-responsive.
Component A requires applicants to hold public health authority, legislative mandate, or legal access to clinic-based surveillance data from multiple sources capturing prenatal exposures (alcohol use, polysubstance use) and conditions including fetal alcohol spectrum disorders, neonatal abstinence syndrome, congenital cytomegalovirus, and other outcomes. This authority documentation must be uploaded as a PDF attachment titled "Legal Authority" or the application will be non-responsive. Component A also funds informatics entities providing technical assistance, data quality improvement, and data dissemination support to surveillance partners. Component B targets entities demonstrating capacity to identify and reach people with FASDs, their families and communities, clinical and public health professionals serving affected populations, and to develop communication materials and quantifiable impact metrics for one or more national target populations. Component C funds national partnership activities to prevent FASDs and improve early identification, support, and care of affected infants and children, including serving as a national FASD resource, advancing evidence-based messaging, building clinical capacity through a lifespan approach, addressing regional and jurisdictional gaps, coordinating translation activities, and evaluating program strategies.
Eligible applicants include state governments, county governments, city and township governments, special district governments, federally recognized tribal governments, nonprofit organizations (501(c)(3) and non-501(c)(3)), private and public higher education institutions, independent school districts, for-profit organizations, small businesses, and tribal organizations not federally recognized. The program is funded under Assistance Listing 93.073, Birth Defects and Developmental Disabilities—Prevention and Surveillance. Period of performance is up to five years with an initial 12-month budget period, renewable for one to four additional years contingent on satisfactory progress.
Forecast synopsis
CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO) DD-27-0028, Maternal Child Surveillance and Partnerships for Action, Results, and Knowledge. This NOFO will integrate maternal child health surveillance with national partnership activities to address key public health challenges including alcohol use during pregnancy, fetal alcohol spectrum disorders (FASDs), neonatal abstinence syndrome (NAS), and cytomegalovirus (CMV).
The NOFO will support entities with appropriate data authority and infrastructure to initiate, sustain, enhance, and/or expand clinical surveillance systems capturing data on pregnant women, infants, and/or children. Funding will prioritize improving data quality and enabling timely reporting and dissemination of evolving outcome data.
Funded entities participating in clinical surveillance will monitor prenatal exposures such as alcohol use and polysubstance use during pregnancy as well as conditions with significant public health impact such as FASDs, NAS, congenital CMV, and other outcomes. CDC will also fund entities with informatics expertise to provide technical assistance to funded entities conducting clinical surveillance, improve data quality, and support dissemination of data through visualizations. Furthermore, this clinical surveillance network could be leveraged to address emerging, reemerging, and persistent public health threats to pregnant women and infants.
In addition, this NOFO will invest in national partnership activities to prevent FASDs and improve early identification as well as support and care of affected infants and children. Activities may include serving as a national FASD resource; advancing evidence-based messaging; building clinical capacity through a holistic, lifespan approach; addressing regional, state, local, and/or tribal jurisdiction gaps; advancing coordination and translation of activities; and evaluating program strategies.
Together, these activities establish a combined framework that emphasizes data to action approaches that translate high quality surveillance data into prevention strategies, pathways to referral and support, and improved outcomes.
Eligibility
The NOFO has three components: Component A, Component B, and Component C. Eligible applicants may apply for only one component. If an applicant submits multiple applications, all applications submitted by that applicant will be deemed non-responsive, and will not receive further review. In the "Descriptive Title of Applicant's Project" on the SF-424 form, applicants must identify the component and, as applicable, the strategies for which they are applying. Applicants that do not identify the applicable components and strategies on the SF-424 form will be deemed non-responsive and will not receive further review. Eligible applicants for Component A must have the public health authority, legislative mandate or otherwise show legal access to the requisite data to conduct clinic-based surveillance. This authority or access must allow unique and specific access to datasets from multiple data sources that are required to implement the activities outlined in this NOFO. Eligible applicants must upload this documentation as a PDF to www.grants.gov under "Other Attachment Forms" using the attachment name "Legal Authority".CDC will consider any application that does not include this required documentation as non-responsive, and it will receive no further review. Eligible applicants for Component B must demonstrate their ability and capacity to identify and reach one or more target populations, which include people with FASDs, their families, and/or their communities, as well as clinical and public health professionals, who serve patients or clients who could be impacted by FASDs, across the United States. Applicants must also demonstrate their ability to develop new communication materials and continually identify and update resources that could be applied to one or more target populations, as well as quantify metrics of impact. Applicant's history of outreach to these populations should include, but may not be limited to, evidence-based educational information, resources, and support.Eligible applicants for Component C must be able to demonstrate ability to provide informatics and technical support to Component A applicants supporting standardized data collection, quality assurance, and timely data submission.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity